FR2315944A1 - Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms - Google Patents

Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Info

Publication number
FR2315944A1
FR2315944A1 FR7521147A FR7521147A FR2315944A1 FR 2315944 A1 FR2315944 A1 FR 2315944A1 FR 7521147 A FR7521147 A FR 7521147A FR 7521147 A FR7521147 A FR 7521147A FR 2315944 A1 FR2315944 A1 FR 2315944A1
Authority
FR
France
Prior art keywords
immunitary
stimulants
contg
microorganisms
human mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7521147A
Other languages
French (fr)
Other versions
FR2315944B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7521147A priority Critical patent/FR2315944A1/en
Publication of FR2315944A1 publication Critical patent/FR2315944A1/en
Application granted granted Critical
Publication of FR2315944B1 publication Critical patent/FR2315944B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A pharmaceutical preparation contains, separately, a proteinic extract (I) and a lipidic extract (II) from a mixt. of common saprophytic micro-organisms existing in human mucosa and belonging to the following types: Neisseria, Hemophilus, Klebsellia, Pseudomonas, Proteus, Streptococcus, and Staphylococcus. Used in non-specific immunitary stimulators. (I) and (II) are normally administered parenterally, in succession. (I) is given in physiological serum at a dose of 5-20 mg/5ml, (II) is given in a sterile oily excipient at a dose of 1-5 mg/5ml.
FR7521147A 1975-07-04 1975-07-04 Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms Granted FR2315944A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7521147A FR2315944A1 (en) 1975-07-04 1975-07-04 Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7521147A FR2315944A1 (en) 1975-07-04 1975-07-04 Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Publications (2)

Publication Number Publication Date
FR2315944A1 true FR2315944A1 (en) 1977-01-28
FR2315944B1 FR2315944B1 (en) 1978-10-06

Family

ID=9157558

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7521147A Granted FR2315944A1 (en) 1975-07-04 1975-07-04 Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Country Status (1)

Country Link
FR (1) FR2315944A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426470A1 (en) * 1978-05-26 1979-12-21 Om Lab Sa IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426470A1 (en) * 1978-05-26 1979-12-21 Om Lab Sa IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT

Also Published As

Publication number Publication date
FR2315944B1 (en) 1978-10-06

Similar Documents

Publication Publication Date Title
Kohwi et al. Antitumor effect of Bifidobacterium infantis in mice
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
RU94046424A (en) Method of separation of dna-ase forms, human dna-ase, pharmaceutical composition, method of dna-ase storage, treatment method
DE3485581D1 (en) ANTIOESTROGEN MEDICINAL PRODUCT FOR PERCUTANEOUS ADMINISTRATION.
DE59811158D1 (en) USE OF ERYTHROPOIETIN AND IRON PREPARATIONS FOR THE PRODUCTION OF PHARMACEUTICAL COMBINATION PREPARATIONS FOR THE TREATMENT OF RHEUMATIC DISEASES
PL335370A1 (en) Orally administered preparation for preventing and treating bacterial infections caused by helicobacter sp.
Sullivan et al. Enkephalin in peripheral neuroendocrine tumours
KR100472061B1 (en) Bacteria strains and pharmaceutical compositions containing such strains and their use as a prophylaxis and treatment of diseases caused by or associated with modified bile acid metabolism
Pappenheimer Bayliss-Starling Memorial Lecture (1982). Induction of sleep by muramyl peptides.
ES2112818T1 (en) PHARMACEUTICAL COMPOSITION INCLUDING LACTOBACILLUS PLANTARUM AND ARGININ.
CA2382887A1 (en) Immunopotentiating compositions
SE9704584L (en) Preparation of Conjugated Linoleic Acid
JPH05500803A (en) Biological products and their use
FR2315944A1 (en) Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms
IT1306201B1 (en) SUITABLE COMPOSITION AS A FOOD SUPPLEMENT AND FOR THERAPEUTIC TREATMENT OF INTESTINAL DISORDERS AND FLORA ALTERATIONS
Kourounakis et al. Effect of Freund's adjuvant on the mitogenic responses of rat lymphocytes.
Leers et al. Suppurative thyroiditis: an unusual case caused by Actinomyces naeslundi
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
Hiroshi et al. Inhibition of drug-metabolizing enzymes in the mouse after treatment with host-mediating antitumor drugs
姚卫海 et al. Clinical observation on the immediate hypotensive effect of zanzhu point
Carvel et al. Therapeutic effect of water-soluble bioflavonoids in gingival inflammatory conditions
Woodward et al. The beneficial effect of chloromycetin in brucellosis
Kobayashi et al. Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes
EG17992A (en) Preparation of a medicament for arthritis and theumatism
JPH0149246B2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse